UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.

I discuss and analyze UNH's cautious FY2025 guidance, attributing lower bottom-line to various factors. Click here to read my ...

UnitedHealth earnings topped forecasts, but the Dow Jones member lowered the top end of its full-year outlook.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

Shares of UnitedHealth Group tumbled Tuesday as the company lowered its full-year outlook to reflect the impact of a February ...

UnitedHealth's lower 2025 earnings outlook than expected leads to a sell-off, affecting its managed care rivals like ...

Mizuho Securities analyst Ann Hynes has assigned their bullish stance on UNH stock, giving a Buy rating today. Ann Hynes has given her Buy ...

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of ...

Quarterly profit of $6.06 billion at the Minnetonka-based company beat analyst estimates on a per-share basis as revenue grew ...

What Are The Key Trends To Drive UnitedHealth’s Q3 Results? UnitedHealth should continue to benefit from an increase in total ...

Ascension Health, a chain of Catholic hospitals in the U.S., was the victim of a cyberattack that disrupted operations, the company said Wednesday. UnitedHealth CEO Andrew Witty testified before a ...

The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...